Monoclonal Antibody against Mouse CAR following Genetic Immunization

Hybridoma and Hybridomics

Volumn 23, Issue 1, 2004, Pages 19-22

  Carson, Steven D ^a   Switzer, Barbara L ^a   Tracy, Steven M ^a   Chapman, Nora M ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY;

ANIMAL TISSUE; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DIMERIZATION; ESCHERICHIA COLI; EXPRESSION VECTOR; FEMALE; FETUS; GENE EXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; HYBRIDOMA; IMMUNE SYSTEM; IMMUNIZATION; IMMUNOGLOBULIN PRODUCTION; IMMUNOSTIMULATION; INOCULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CELL LINE; DIMERIZATION; DNA, COMPLEMENTARY; GENETIC VECTORS; MICE; RECEPTORS, VIRUS;

ADENOVIRIDAE; ANIMALIA; COXSACKIEVIRUS; ESCHERICHIA COLI; VECTORS;

EID: 1242294515     PISSN: 15368599     EISSN: None     Source Type: Journal    
DOI: 10.1089/153685904322771980     Document Type: Article

References (21)

1. Aurrand-Lions M, Johnson-Leger C, Wong C, Du Pasquier L, and Imhof BA: Heterogeneity of endothelial junctions is reflected by differential expression and specific subcellular localization of the three JAM family members. Blood 2001;98:3699-3707.
2. Hirata K, Ishida T, Penta K, Rezaee M, Yang E, Wohlgemuth J, and Quertermous T: Cloning of an immunoglobulin family adhesion molecule selectively expressed by endothelial cells. J Biol Chem 2001;276:16223-16231.
3. Johnstone CN, Tebbutt NC, Abud HE, White SJ, Stenvers KL, Hall NE, Cody SH, Whitehead RH, Catimel B, Nice EC, Burgess AW, and Heath JK: Characterization of mouse A33 antigen, a definitive marker for basolateral surfaces of intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 2000;279:G500-G510.
4. Cohen CJ, Shieh JT, Pickles RJ, Okegawa T, Hsieh J-T, and Bergelson JM: The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. Proc Natl Acad Sci USA 2001;98:15191-15196.
5. Dejana E, Spagnuolo R, and Bazzoni G: Interendothelial junctions and their role in the control of angiogenesis, vascular permeability and leukocyte transmigration. Thromb Haemost 2001;86:308-315.
6. Hsu KH, Lonberg-Holm K, Alstein B, and Crowell RL: A monoclonal antibody specific for the cellular receptor for the group B coxsackieviruses. J. Virol. 1988;62:1647-1652.
7. Carson SD, Hobbs JT, Tracy SM, and Chapman NM: Expression of the coxsackievirus and adenovirus receptor in cultured human umbilical vein endothelial cells: regulation in response to cell density. J Virol 1999;73:7077-7079.
8. Bergelson JM, Modlin JF, Wieland-Alter W, Cunningham JA, Crowell RL, and Finberg RW: Clinical coxsackievirus B isolates differ from laboratory strains in their interaction with two cell surface receptors. J Infect Dis 1997;175:697-700.
9. Hidaka C, Milano E, Leopold PL, Bergelson JF, Hackett NR, Finberg RW, Wickham TJ, Kovesdi I, Roelvink P, and Crystal RG: CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts. J Clin Invest 1999;103:579-587.
10. Carson SD: Limited proteolysis of the coxsackievirus and adeno-virus receptor (CAR) on HeLa cells exposed to trypsin. FEBS Lett 2000;484:149-152.
11. Williams RS, Johnston SA, Riedy M, DeVit MJ, McElligott SG, and Sanford JC: Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles. Proc Natl Acad Sci USA 1991;88:2726-2730.
12. Cunningham KA, Chapman NM, and Carson SD: Caspase-3 activation and ERK phosphorylation during CVB3 infection of cells: influence of the coxsackievirus and adenovirus receptor and engineered variants. Virus Res 2003;92:179-186.
13. Sawant SV, Singh PK, and Tuli R: Pretreatment of microprojectiles to improve the delivery of DNA in plant transformation. Biotechniques 2000;29:246-248.
14. Forg P, Hoegen Pv, Dalemans W, and Schirrmacher V: Superiority of the ear pinna over muscle tissue as site for DNA vaccination. Gene Ther 1998;5:789-797.
15. Carson SD, and Chapman NM: Coxsackievirus and adenovirus receptor (CAR) binds immunoglobulins. Biochemistry 2001;40: 14324-14329.
16. Johnson D: Murine monoclonal antibody development. In: Paul S, ed. Methods in Molecular Biology. Vol. 51. Humana Press, 1995, pp. 123-137.
17. Engvall E: Enzyme immunoassay ELISA and EMIT. Methods Enzymol 1980;70:419-139.
18. Thoelen I, Magnusson C, Tagerud S, Polacek C, Lindberg M, and Ranst MV: Identification of alternative products encoded by the human coxsackie- adenovirus receptor gene. Biochem Biophys Res Commun 2001;287:216-222.
19. Bernal RM, Sharma S, Gardner BK, Douglas JT, Bergelson JM, Dubinett SM, and Batra RK: Soluble coxsackievirus adenovirus receptor is a putative inhibitor of adenoviral gene transfer in the tumor milieu. Clin Cancer Res 2002;8:1915-1923.
20. Liu J, Wei Y, Yang L, Zhao X, Tian L, Hou J, Niu T, Niu F, Jiang Y, Hu B, Wu Y, Su J, Lou Y, He Q, Yang J, Kan B, Mao Y, Luo F, and Peng F: Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor-2. Blood 2003;102:1815-1823.
21. van Raaij MJ, Chouin E, van der Zandt H, Bergelson JM, and Cusack S: Dimeric structure of the coxsackievirus and adenovirus receptor D1 domain at 1. 7 A resolution. Struct Fold Des 2000;8: 1147-1155.